Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers

@article{Joshi2010AgerelatedFC,
  title={Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers},
  author={Shilpa Joshi and Stephen Lewis and Siobhan Creanor and Ruth M Ayling},
  journal={Annals of Clinical Biochemistry},
  year={2010},
  volume={47},
  pages={259 - 263}
}
Objective Measurement of the faecal markers calprotectin, lactoferrin and tumour M2-PK has been reported to be useful in the diagnosis and management of a range of gastrointestinal disorders in both children and adults. The aim of this study was to investigate the requirement for age-related reference ranges. Methods Faecal samples were obtained from 132 healthy subjects and analysis of calprotectin, lactoferrin and tumour M2-PK performed using commercially available enzyme-linked immunosorbent… Expand
Paediatric reference ranges for faecal calprotectin: a UK study
TLDR
In this local population, children aged 1–3.9 years had higher concentrations of faecal calprotectin than adults, but there was no significant difference between older children and adults, in agreement with other published studies. Expand
Concentration of fecal calprotectin in 11,255 children aged 0–18 years
TLDR
Fecal calprotectin values in children beyond the first year of life are in general low and comparable in children and adolescents. Expand
Faecal calprotectin as a marker for oesophago-gastric cancer
TLDR
It is suggested that calprotectin may be promising in discriminating cancer patients from controls, but further work is required to explore any potential role of faecal cal Protectin in screening for, or diagnosis of, oesophago-gastric cancer. Expand
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old.
  • Millie Garg, S. Leach, +11 authors C. Y. Ooi
  • Medicine
  • Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
  • 2018
TLDR
Fecal M2-PK was elevated in children with CF compared with HC during infancy and throughout childhood suggesting abnormalities in the CF gut exist in early life. Expand
Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients
TLDR
Fecal calprotectin levels are significantly higher than the reference value in most patients after RYGB and Fecal elastase is significantly lower, which might indicate that the validity of fecal cal Protectin testing is impaired after RyGB and the specificity for fecal elASTase is decreased. Expand
Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.
  • Millie Garg, S. Leach, +11 authors C. Y. Ooi
  • Medicine
  • Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
  • 2017
TLDR
Fecal calprotectin levels in children with CF and HC were age-dependent and had distinct trajectories, and careful interpretation is required if used in drug trials for CF, particularly in children less than 4years old. Expand
Role of Fecal Calprotectin in Diagnosis and Follow up of Hepatic Encephalopathy
TLDR
Significant high levels of fecal calprotectin in high grade HE patients and its reduction following effective treatment could consider fecal Calprotectin as a follow up marker in association with clinical signs in patients with HE. Expand
Fecal calprotectin in healthy children aged 4–16 years
TLDR
A nomogram is proposed to facilitate the interpretation of fCP results in children aged 4–16 years and it is found a statistically significant association between the 95th percentile of f CP concentrations and age (p < 0.001). Expand
Age-Related Fecal Calprotectin Concentrations in Healthy Adults
TLDR
The baseline data for differential diagnoses of inflammatory bowel disease is provided and a suitable cut-off value is required for different ages, confirming the significant correlation between age and FC concentration. Expand
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
TLDR
Evaluated and compared the performance of the Immunodiagnostik, Bühlmann and Eurospital f-Cp ELISA assays as well as the Roche, immunosorbent and ScheBo Biotech commercial faecal extraction devices and briefly reports results from a pilot EQA scheme. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
TLDR
Fecal calprotectin and lactoferrin appear to be equally recommendable as inflammatory disease markers in patients with lower gastrointestinal symptoms and both tests are needed to accurately discriminate activity in inflammatory bowel disease patients. Expand
Fecal Lactoferrin Is a Sensitive and Specific Marker in Identifying Intestinal Inflammation
TLDR
Fecal lactoferrin is sensitive and specific for detecting inflammation in chronic IBD and may prove useful in screening for inflammation in patients presenting with abdominal pain and diarrhea. Expand
Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease
TLDR
Fecal calprotectin seems to reflect bowel inflammation in children with IBD as a simple, safe, noninvasive test, which has the potential to reduce the number of invasive investigations performed in these children. Expand
Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.
TLDR
Fecal calprotectin was significantly correlated to fecal alpha 1-antitrypsin in the patients with Crohn's disease and ten of 11 patients with gastrointestinal carcinomas had calprotectIn level above the suggested reference limit of 6740 micrograms/l. Expand
Metabolic and inflammatory faecal markers in collagenous colitis
TLDR
Faecal cal Protectin was increased in collagenous colitis; however, increased excretion was not a universal finding limiting the use of calprotectin as an inflammatory marker in collagenus colitis. Expand
Fecal dimeric M2‐pyruvate kinase (tumor M2‐PK) in the differential diagnosis of functional and organic bowel disorders
TLDR
Tumor M2‐PK is able to differentiate organic from functional bowel disease but has a lower sensitivity, specificity, and predictive value than calprotectin. Expand
Fecal Lactoferrin: A New Parameter to Monitor Infliximab Therapy
TLDR
Fecal lactoferrin is a sensitive and specific biomarker representing intestinal inflammation and response to therapy in pediatric patients with Crohn's disease and may be a helpful noninvasive diagnostic tool for monitoring therapeutic efficiency in pediatric IBD patients. Expand
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
TLDR
The purpose of the present study was to evaluate whether normalization of faecal calprotectin in patients with UC and Crohn disease (CD) could be a marker of mucosal healing. Expand
Fecal pyruvate kinase-M2 (tumor M2-PK) measurement: a new screening concept for colorectal cancer.
TLDR
Measurement of tumor M2-PK in feces seems to be the most promising tool for CRC screening at the present time and in combination with colonoscopy, this test should hence be recommended for CRC screenings programs. Expand
Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children
TLDR
Faecal calprotectin concentration, a measure of intestinal inflammation, in infants and children with abdominal pain, was measured by an enzyme‐linked immunosorbent assay kit in spot stool samples in 76 infants with typical infantile colic, 7 infants with transient lactose intolerance and 27 healthy infants. Expand
...
1
2
3
4
...